世界のHIVの診断&治療市場 2019年

QYResearchが発行した調査報告書(QYR20FB00145)
◆英語タイトル:Global HIV Diagnosis & Treatment Market Professional Survey Report 2019
◆商品コード:QYR20FB00145
◆発行会社(リサーチ会社):QYResearch
◆発行日:2019年11月5日(※2024年版があります。お問い合わせください。)
◆ページ数:102
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,500 ⇒換算¥518,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,250 ⇒換算¥777,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,000 ⇒換算¥1,036,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

※本調査レポートは、HIVの診断&治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ELISA検査、唾液検査、ウイルス負荷検査、ウェスタンブロット、その他に、用途別には、病院、診療所にセグメント区分し、HIVの診断&治療の世界市場を分析しました。


・エグゼクティブ・サマリー
・HIVの診断&治療の世界市場概要
・HIVの診断&治療の製造コスト構成分析
・HIVの診断&治療の開発・製造工場分析
・主要メーカーの主な指標(生産能力、売上、価格分析)
・HIVの診断&治療の地域別分析(生産、売上、主要メーカー、輸出・輸入)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・HIVの診断&治療のセグメント分析(種類別)
(ELISA検査、唾液検査、ウイルス負荷検査、ウェスタンブロット、その他)
・HIVの診断&治療のセグメント分析(用途別)
(病院、診療所)
・HIVの診断&治療の主要メーカー別分析(生産拠点、製品概要、生産・売上実績)
(Abbott Laboratories、Boehringer Ingelheim、Bristol-Myers Squibb、Cipla、F. Hoffmann-La Roche、Gilead、GlaxoSmithKline、Johnson & Johnson)
・HIVの診断&治療の市場規模予測(2019年~2025年)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス(市場動向、機会、成長要因、課題、影響因子)
...
【レポートの概要】

HIV prevalence in Africa, specifically in Southern region is very high as compared to North African region. Approximately 1 out of 4 is suffering from HIV. Southern and Eastern region of Africa has one of the highest prevalence rate of HIV, about 19 million people have HIV. While HIV prevalence is low in North Africa but the number of cases of HIV are increasing rapidly. There is no cure for HIV but drugs manufacturing companies are investing huge money in R&D to develop drugs for HIV.Over 3000 patients were died in sub Saharan Africa due to HIV in 2015. Following 10 countries from Africa consists of 80% of total HIV burden which are South Africa, Kenya, Malawi, Ethiopia, Mozambique, United Republic of Tanzania, Nigeria, Uganda, Zimbabwe and Zambia.

The global HIV Diagnosis & Treatment market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on HIV Diagnosis & Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall HIV Diagnosis & Treatment market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of HIV Diagnosis & Treatment in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their HIV Diagnosis & Treatment manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Abbott Laboratories
Boehringer Ingelheim
Bristol-Myers Squibb
Cipla
F. Hoffmann-La Roche
Gilead
GlaxoSmithKline
Johnson & Johnson

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
ELISA Test
Saliva Tests
Viral Load Test
Western Blot
Others

Segment by Application
Hospitals
Clinics

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of HIV Diagnosis & Treatment
1.1 Definition of HIV Diagnosis & Treatment
1.2 HIV Diagnosis & Treatment Segment by Type
1.2.1 Global HIV Diagnosis & Treatment Production Growth Rate Comparison by Types (2014-2025)
1.2.2 ELISA Test
1.2.3 Saliva Tests
1.2.4 Viral Load Test
1.2.5 Western Blot
1.2.6 Others
1.3 HIV Diagnosis & Treatment Segment by Applications
1.3.1 Global HIV Diagnosis & Treatment Consumption Comparison by Applications (2014-2025)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global HIV Diagnosis & Treatment Overall Market
1.4.1 Global HIV Diagnosis & Treatment Revenue (2014-2025)
1.4.2 Global HIV Diagnosis & Treatment Production (2014-2025)
1.4.3 North America HIV Diagnosis & Treatment Status and Prospect (2014-2025)
1.4.4 Europe HIV Diagnosis & Treatment Status and Prospect (2014-2025)
1.4.5 China HIV Diagnosis & Treatment Status and Prospect (2014-2025)
1.4.6 Japan HIV Diagnosis & Treatment Status and Prospect (2014-2025)
1.4.7 Southeast Asia HIV Diagnosis & Treatment Status and Prospect (2014-2025)
1.4.8 India HIV Diagnosis & Treatment Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of HIV Diagnosis & Treatment
2.3 Manufacturing Process Analysis of HIV Diagnosis & Treatment
2.4 Industry Chain Structure of HIV Diagnosis & Treatment

3 Development and Manufacturing Plants Analysis of HIV Diagnosis & Treatment
3.1 Capacity and Commercial Production Date
3.2 Global HIV Diagnosis & Treatment Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of HIV Diagnosis & Treatment
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 HIV Diagnosis & Treatment Production and Capacity Analysis
4.2 HIV Diagnosis & Treatment Revenue Analysis
4.3 HIV Diagnosis & Treatment Price Analysis
4.4 Market Concentration Degree

5 HIV Diagnosis & Treatment Regional Market Analysis
5.1 HIV Diagnosis & Treatment Production by Regions
5.1.1 Global HIV Diagnosis & Treatment Production by Regions
5.1.2 Global HIV Diagnosis & Treatment Revenue by Regions
5.2 HIV Diagnosis & Treatment Consumption by Regions
5.3 North America HIV Diagnosis & Treatment Market Analysis
5.3.1 North America HIV Diagnosis & Treatment Production
5.3.2 North America HIV Diagnosis & Treatment Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America HIV Diagnosis & Treatment Import and Export
5.4 Europe HIV Diagnosis & Treatment Market Analysis
5.4.1 Europe HIV Diagnosis & Treatment Production
5.4.2 Europe HIV Diagnosis & Treatment Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe HIV Diagnosis & Treatment Import and Export
5.5 China HIV Diagnosis & Treatment Market Analysis
5.5.1 China HIV Diagnosis & Treatment Production
5.5.2 China HIV Diagnosis & Treatment Revenue
5.5.3 Key Manufacturers in China
5.5.4 China HIV Diagnosis & Treatment Import and Export
5.6 Japan HIV Diagnosis & Treatment Market Analysis
5.6.1 Japan HIV Diagnosis & Treatment Production
5.6.2 Japan HIV Diagnosis & Treatment Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan HIV Diagnosis & Treatment Import and Export
5.7 Southeast Asia HIV Diagnosis & Treatment Market Analysis
5.7.1 Southeast Asia HIV Diagnosis & Treatment Production
5.7.2 Southeast Asia HIV Diagnosis & Treatment Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia HIV Diagnosis & Treatment Import and Export
5.8 India HIV Diagnosis & Treatment Market Analysis
5.8.1 India HIV Diagnosis & Treatment Production
5.8.2 India HIV Diagnosis & Treatment Revenue
5.8.3 Key Manufacturers in India
5.8.4 India HIV Diagnosis & Treatment Import and Export

6 HIV Diagnosis & Treatment Segment Market Analysis (by Type)
6.1 Global HIV Diagnosis & Treatment Production by Type
6.2 Global HIV Diagnosis & Treatment Revenue by Type
6.3 HIV Diagnosis & Treatment Price by Type

7 HIV Diagnosis & Treatment Segment Market Analysis (by Application)
7.1 Global HIV Diagnosis & Treatment Consumption by Application
7.2 Global HIV Diagnosis & Treatment Consumption Market Share by Application (2014-2019)

8 HIV Diagnosis & Treatment Major Manufacturers Analysis
8.1 Abbott Laboratories
8.1.1 Abbott Laboratories HIV Diagnosis & Treatment Production Sites and Area Served
8.1.2 Abbott Laboratories Product Introduction, Application and Specification
8.1.3 Abbott Laboratories HIV Diagnosis & Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Boehringer Ingelheim
8.2.1 Boehringer Ingelheim HIV Diagnosis & Treatment Production Sites and Area Served
8.2.2 Boehringer Ingelheim Product Introduction, Application and Specification
8.2.3 Boehringer Ingelheim HIV Diagnosis & Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Bristol-Myers Squibb
8.3.1 Bristol-Myers Squibb HIV Diagnosis & Treatment Production Sites and Area Served
8.3.2 Bristol-Myers Squibb Product Introduction, Application and Specification
8.3.3 Bristol-Myers Squibb HIV Diagnosis & Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Cipla
8.4.1 Cipla HIV Diagnosis & Treatment Production Sites and Area Served
8.4.2 Cipla Product Introduction, Application and Specification
8.4.3 Cipla HIV Diagnosis & Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 F. Hoffmann-La Roche
8.5.1 F. Hoffmann-La Roche HIV Diagnosis & Treatment Production Sites and Area Served
8.5.2 F. Hoffmann-La Roche Product Introduction, Application and Specification
8.5.3 F. Hoffmann-La Roche HIV Diagnosis & Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Gilead
8.6.1 Gilead HIV Diagnosis & Treatment Production Sites and Area Served
8.6.2 Gilead Product Introduction, Application and Specification
8.6.3 Gilead HIV Diagnosis & Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 GlaxoSmithKline
8.7.1 GlaxoSmithKline HIV Diagnosis & Treatment Production Sites and Area Served
8.7.2 GlaxoSmithKline Product Introduction, Application and Specification
8.7.3 GlaxoSmithKline HIV Diagnosis & Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Johnson & Johnson
8.8.1 Johnson & Johnson HIV Diagnosis & Treatment Production Sites and Area Served
8.8.2 Johnson & Johnson Product Introduction, Application and Specification
8.8.3 Johnson & Johnson HIV Diagnosis & Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served

9 Development Trend of Analysis of HIV Diagnosis & Treatment Market
9.1 Global HIV Diagnosis & Treatment Market Trend Analysis
9.1.1 Global HIV Diagnosis & Treatment Market Size (Volume and Value) Forecast 2019-2025
9.2 HIV Diagnosis & Treatment Regional Market Trend
9.2.1 North America HIV Diagnosis & Treatment Forecast 2019-2025
9.2.2 Europe HIV Diagnosis & Treatment Forecast 2019-2025
9.2.3 China HIV Diagnosis & Treatment Forecast 2019-2025
9.2.4 Japan HIV Diagnosis & Treatment Forecast 2019-2025
9.2.5 Southeast Asia HIV Diagnosis & Treatment Forecast 2019-2025
9.2.6 India HIV Diagnosis & Treatment Forecast 2019-2025
9.3 HIV Diagnosis & Treatment Market Trend (Product Type)
9.4 HIV Diagnosis & Treatment Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 HIV Diagnosis & Treatment Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

...

【掲載企業】

Abbott Laboratories、Boehringer Ingelheim、Bristol-Myers Squibb、Cipla、F. Hoffmann-La Roche、Gilead、GlaxoSmithKline、Johnson & Johnson

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のHIVの診断&治療市場 2019年(Global HIV Diagnosis & Treatment Market Professional Survey Report 2019)]についてメールでお問い合わせはこちらでお願いします。